Excl Presentation / Workshop

Dr. Alaa Saeed Mutalq

Consultant Internal Medicine Clinical Pharmacist, Dy Director General Administration of Pharmaceutical Care & Manager of Clinical Pharmacy Department (MOH). | Saudi Arabia

Alaa Saeed Mutalq is a consultant internal medicine clinical pharmacist. Dr. Mutlaq is working as deputy director of general administration of pharmaceutical care and manager of Clinical Pharmacy department in Saudi Ministry of Health (MOH). She graduated from King Saud University, and she is also certified with the Saudi board of clinical pharmacy in internal medicine. She is practicing as an internal medicine clinical pharmacist at King Salman Hospital, Saudi Arabia. She received several awards, rewarding the best senior clinical pharmacy resident at Prince Sultan Military Medical City, also rewarding the Ideal employer 2021 at deputyship of therapeutic affairs, MOH. She is a member of clinical pharmacy scientific council. She has many presentations and research to her credit

Dr. Saleh Almekhloof

Critical Care Pharmacist | Saudi Arabia

Dr. Saleh Almekhloof is a critical care clinical pharmacist at King Abdulaziz Hospital (KAH), Ministry of National Guards, Hofuf, since 2017. He earned his Doctor of Pharmacy degree from MCPHS University, Worcester City, United States, in 2015. Soon after, he completed his PGY-1 pharmacy practice residency program at Melrose- Wakefield Hospital, Boston city, United States in 2016. He held several leadership roles in medication safety and optimal medication use process. His top interest is optimizing antibiotic regimens based on age, disease state, and pharmacokinetics & pharmacodynamics. He is also interested in research, teaching, training, as well as developing updated therapeutic protocols.

Dr. Juhaina Al Maqbali,

B.Sc., M.Sc., Clinical Pharmacist, Senior Pharmacist Specialist, Sultan Qaboos University Hospital, Muscat, | Oman

Juhaina graduated with a Bachelor of Pharmacy degree with honour from Oman Medical College in 2011. Then she was awarded a Master's Degree in clinical pharmacy from Sultan Qaboos University in 2014. Juhaina works as a senior specialist pharmacist at the Department of Pharmacy, Sultan Qaboos University Hospital. Besides the busy clinical work, Juhaina developed five hospital-wide protocols and guidelines to improve the safety and quality of medications and health care delivery at SQUH. Also, she had 16 peer-reviewed journal publications focusing on pharmacy-related aspects of caring for adult general medicine patients. Also, she contributed to supervising Master of Pharmacy Students and developing pharmacy exams for Oman Medical Specialty Board (OMSB). Juhaina is a member of several important hospital and national committees, including the curriculum committee; Oman Medical College (2017-2018); Hospital Incidence Reporting and Closing system (2020); Patient Safety Committee (2019-2022) Juhaina is certified by SIDP for Antimicrobial Stewardship Certificate Program (2020) and by ACCP for International Certificate Program for Comprehensive Medication Management (2021) Currently, Juhaina is an enrolled PhD student at the College of Medicine and Health Sciences, Sultan Qaboos University.

Dr. Aqila Mohammed Hassan Taqi

PhD, MSc Clinical Pharmacy, Senior Specialist Pharmacist (A), Sultan Qaboos University Hospital, Muscat, | Oman

Dr. Aqila Mohammed Hassan Taqi is a senior specialist pharmacist at Sultan Qaboos University Hospital- pharmacy department. She has over 15 years’ experience in clinical pharmacy practice, when she was a clinical pharmacist for paediatrics and bone marrow transplantation services. Aqila was also the pharmacy’s quality representative since 2010 and coordinated the department’s accreditation preparedness activities for both ISO 9001 certification and later on for Accreditation Canada International (ACI) in 2014. Dr. Aqila pursued her PhD in pharmacoepidemiology and clinical pharmacy from the University of Nottingham –UK in July 2020. Her research was on “Analgesic utilisation in patients with knee osteoarthritis” for which she used data from the UK Clinical Practice Research Datalink (CPRD), the world’s largest primary care medical records data base. She has special interest in clinical pharmacy practice and safe use of medications and her work was published in a n umber of peer reviewed scientific journals.

Prof. Silvia E. Rabionet

Dept. Chair at Nova Southeastern University, USA | USA

"Silvia E. Rabionet is an Associate Professor at Nova Southeastern University College of Pharmacy, and Chair of Department of Sociobehavioral and Administrative Pharmacy. She received a B.A. from Mount Holyoke College, and her M.A. and Ed.D. from Harvard University. She has designed and administered numerous training and faculty development grants in the fields of tobacco cessation, public health preparedness, HIV/AIDS, and mentoring, among others. She has developed competency-based models for health workforce development. She has actively participated with the Institute of Medicine, Centers for Disease Control and Prevention, Pan American Health Organization, World Health Organization, and other national and international networks in the development of materials and technical reports for workforce development, inclusive of equity and social justice perspectives. She teaches Public Health and Health Promotion at the master’s, Pharm.D. and Ph.D. levels. She has expertise in the design of behavioral health promotion, disease prevention, and public health interventions. She has been principal and co-investigator in various research projects: non-medical use of prescription drugs among students; adherence to HAART in the Caribbean and South Florida; health literacy and HIV patients; life stories of youth born with HIV, among others. She is the program director of a National Institute of Mental Health–funded mentoring project on HIV and mental health. The project facilitates the research development of minority junior faculty and doctoral students. These initiatives have provided comprehensive support to early career investigators, including mentoring, methodological skills development (quantitative and qualitative), and multi-institution networking. She has published about public health history and education, mentoring, and sociobehavioral aspects of drug use."

Prof. Abdullah Molokhia

PhD., Professor, Pharmaceutics, Egypt. | Egypt

Professor, Pharmaceutics Former Chairman, National Organization for Drug Control And Research, Egypt

Prof. Robert Sindelar,

PhD, FCAHS, Professor and Former Dean, Faculty of Pharmaceutical Sciences, The University of British Columbia, Canada | Canada

"Professor Robert D. Sindelar, Ph.D., FFIP, FCAHS Dr. Sindelar is a Professor and Dean Emeritus, Faculty of Pharmaceutical Sciences, University of British Columbia (UBC). Dr. Sindelar is also an elected fellow of the Canadian Academy of Health Sciences, and an elected fellow of the International Pharmaceutical Federation (FIP). Currently, he serves as the Chair of the FIP “Global Pharmacy Observatory Data & Intelligence Presidential Commission, to provide strategic advice on the development of the Global Pharmaceutical Observatory working with FIP stakeholders including WHO. He is also the Head of Pharmaceutical Sciences, the Athens Institute for Education and Research. Professor Sindelar previously served as Vice President of Innovation, Research & Academic Affairs at Providence Health Care (PHC), President of the PHC Research Institute and Associate Dean Research in the UBC Faculty of Medicine (2013-2016). He is a founder of the Centre for Drug Research and Development (formerly CDRD, now called adMare BioInnovations), a national not-for-profit drug development and commercialization centre. Also, he has served as President of the Global Drug Commercialization Centre (GDCC)-China, and Vice President, GDCC-Worldwide (2017-2019), a translational medicine endeavor that facilitates the innovative development of healthcare initiatives. In these various roles, he continues to contribute to health science research, health policy development, team-building, international partnerships, as well as strategic innovations. Dr. Sindelar completed a M.S. degree and a Ph.D. in Medicinal Chemistry and Natural Products at the University of Iowa School of Pharmacy. His research expertise is in medicinal chemistry, computer-aided drug discovery, and pharmaceutical biotechnology. He is the recipient of several School and University-wide teaching honors and has co-edited 5 editions of the highly successful textbook entitled “Pharmaceutical Biotechnology: Fundamentals and Applications.” "

Prof. Barry A. Bleidt

PhD, PharmD, RPh, FAPhA, FNPhA, Professor, Sociobehavioral and Administrative Pharmacy, USA | USA

Barry A. Bleidt, PhD, PharmD, RPh, FAPhA. Dr. Bleidt is a Professor of Sociobehavioral and Administrative Pharmacy at Nova Southeastern University College of Pharmacy. He received his BS Pharmacy from the University of Kentucky, PhD in Pharmacy Healthcare Administration from the University of Florida, and his PharmD from Xavier University of Louisiana. Barry has over forty years of professional experience in preventing drug use problems and substance misuse, looking at quality Pharmacy services, and looking towards the future of the profession. Dr. Bleidt served the past six years as Chair of the Program Committee for the Pharmacy Section of the American Public Health Association and fourteen years for the Alcohol, Tobacco, and Other Drugs Section, twenty-three years as the parliamentarian of the American Association of Colleges of Pharmacy, and twenty-one years as the Director of Continuing Pharmacy Education for the National Pharmaceutical Association. He has served as a Delegate to the United States Pharmacopoeia Convention from 1985 to 2020. Dr. Bleidt has also serves as the Coordinator of Certificate Programs at Nova Southeastern University College of Pharmacy and has been involved with the Immunization Certification Training of over 1,500 pharmacists, pharmacy interns, and student pharmacists. Dr. Bleidt has delivered over 400 presentations and published nearly fifty works. Some of his publications include the books: Clinical Research in Pharmaceutical Development, Multicultural Pharmaceutical Education, and A Guide to the Top 200 Drugs. Dr. Bleidt received the Lifetime Achievement Award from the Pharmacy Section of the American Public Health Association. (2020) He was inducted as a Fellow into the APhA Academy of Pharmaceutical Research and Science in 2015 and as a fellow in the National Pharmaceutical Association (NPhA) in 2016. He received the 2013 Chauncey I Cooper Award (the highest honor bestowed by NPhA), 2007 Award for Innovative and Exemplary Contributions to the NPhA Foundation, the Ilene B. Stiff Local Association President’s Award as the leader of the Virginia Pharmacists Association Local Association of the Year (2001), the James M. Tyson Award (2nd Highest Honor from NPhA (2001); and the American Public Health Association Leadership Award from the Alcohol, Tobacco, and Other Drugs Section (2000). He currently resides in Ft. Lauderdale, Florida. "

Prof. Emad Elazazy

PhD, PharmD, Professor of Governance and Pharmaceutical Practices, Egypt | Egypt

Works as professor of governance practices and Chief Executive Officer of Arab Academy for Excellence in Governance; Research and dissertation advisor at several academic institutions, Manging Director of Arab Governance Alliance, and Senior healthcare consultant. He is also a founding member and secretary general of Egyptian Healthcare Society. Prof Elazazy has been instrumentally contributed towards substantial health and institutional systems governance theory, research, and practices in public, private and civil society, along with their functional oversight at various diligence systems on the ground. He also, enabled distinctive academic governance system assessments and research, healthcare system structuring and reforms, with their variable proficiency aspects and accompanying governance standardisation paradigms at global governance and board governance deployments. Prof Emad had BSc. in Pharmaceutical Sciences; Zagazig University, Master of Business Administration; A.U.C., Doctor of Pharmacy; Saskatchewan, Diploma in International-Economics; Cambridge, PhD in Industrial Management; Aston University, and ultimately Master of Public Administration; Birmingham University. Prof Emad as governance adviser to multifarious corporations’ executive boards, has been focusing on governance domains and methodologies for technical practices in public, and private as well as not-for-profit foundations over the last twenty years. He has directed and supported pioneering governance evolutionary directives at local, regional, and international levels. Besides, he assisted a multitude of leaders and higher executives in the road to enhancing governance codes, institutional operations and, collaborative integration in real-world and healthcare system governance and market enactments, in addition to health sector governance and restructuring contexts.

Dr. Alicia Forinash

Pharm.D., FCCP, BCPS, BCACP, Professor of Pharmacy Practice, St. Louis College of Pharmacy, | USA

"Dr. Alicia B. Forinash is a Professor of Pharmacy Practice at St. Louis College of Pharmacy at the University of Health Sciences and Pharmacy in St. Louis, Missouri. She received her Bachelor of Science in Pharmacy and her Doctor of Pharmacy from St. Louis College of Pharmacy then completed a specialty residency in family medicine at Forest Park Family Medicine and St. Louis College of Pharmacy. Dr. Forinash has practiced for over 15 years at SSM Health St. Mary's in the Maternal-Fetal Care Center and Women and Infant Substance Help (WISH) Center. She is a member of the interprofessional team that manages chronic medical conditions in high risk obstetric patients; evaluates patients for medication safety concerns during pregnancy and lactation; manages acute pregnancy conditions and preventive health issues; and provides patient and healthcare professional education. Similarly, in the WISH center, she participates in the care team for substance abuse disorders during pregnancy. Dr. Forinash is a board-certified specialist in pharmacotherapy (BCPS) and ambulatory care (BCACP) and fellow of ACCP (FCCP). Dr. Forinash has published numerous articles on women's health in both the pharmacy and medical literature. She has co-authored 11th and 12th editions of Briggs Drug Use in Pregnancy and Lactation. She has lectured at numerous conferences on medication usage during pregnancy and lactation. She serves on the editorial board for the Annals of Pharmacotherapy and has served as Chair of the Women’s Health Panel since 2015. She is a member of ACCP, ASHP, and the Organization of Teratology Information Specialists (OTIS). In 2019-20, Dr. Forinash served on the Communications Workgroup of the National Institute of Child Health and Human Development (NICHD) Task Force on Research Specific to Pregnant and Lactating Women (PRGLAC). She was the recipient of the 2019 ACCP Clinical Practice Award and 2021 Next Generation Patient Care Provider of the Year Award.

Prof. Klaus Meier

President ESOP Fellow of the European Academy of Cancer Sciences, Germany | Germany

Vice Director Institute for Applied Healthcare Sceinces (IFAHS) Veritaskai 6 D – 21079 Hamburg Klaus Meier studied theology with the master in 1975, has finished as candidate studies of paedagogics 1975 and the studies of pharmacy in 1981 with the approbation from the ministry of health in Kiel.

Prof. Paul Walker

PharmD, FASHP, President, ASHP & Clinical Professor, Assistant Dean of Experiential Education & Community Engagement, The University of Michigan College of Pharmacy | USA

PharmD, FASHP, FMPA is Clinical Professor and Assistant Dean of Experiential Education and Community Engagement, College of Pharmacy, and Manager, Department of Pharmacy, Michigan Medicine, at the University of Michigan. He previously served in clinical practice and pharmacy leadership roles at the Detroit Medical Center, the Lafayette Clinic, and Henry Ford Health System, and held faculty appointments at Wayne State University. Walker received his BS in Pharmacy and PharmD from Wayne State University. He completed an ASHP‐ accredited residency at Children’s Hospital of Michigan and specialty residency in pediatric pharmacy practice at the University of Tennessee and LeBonheur Children’s Medical Center, Memphis, TN. He served a three‐year term on the American Society of Health‐System Pharmacists (ASHP) Board of Directors and is currently serving as President of the organization. His ASHP service includes Chair, Committee on Nominations; Commission on Affiliate Relations; ASHP Foundation Donor Retention Subcommittee; and Michigan Delegate to the House of Delegates. He recently served as Chair of and Board Liaison to the ASHP Task Force on Racial Diversity, Equity, and Inclusion. Walker has served in leadership positions in the Michigan Pharmacists Association (MPA), and Michigan Society of Health‐System Pharmacists (MSHP). He received several awards from MSHP, including the 2008 MSHP Professional Practice Award, the 2010 MSHP Pharmacist of the Year Award, the 2017 MSHP Joseph A. Odis Leadership Award, and the 2022 MPA Pharmacist of the Year Award. He has been inducted into the MPA Hall of Honor and is recognized as a Fellow of both ASHP and MPA. His interests include pharmacy practice model development; assessment of the impact of pharmacists on patient outcomes; transitions of care; pediatric pharmacotherapy; experiential education and interprofessional education. He has authored numerous peer‐reviewed articles and book chapters, with publications appearing in American Journal of Health System Pharmacy, American Journal of Pharmaceutical Education, and Archives of Internal Medicine, Currents in Pharmacy Teaching and Learning and other journals. He is passionate about advancing pharmacy practice by innovating pharmacist services, evaluating pharmacists’ impact on patient care, and especially by integrating student pharmacists into practice models and interprofessional teams through work in experiential education"

Dr. Tammy S. Cohen,

BS, PharmD, MS, FASHP, FTSHP, FACHEVice President of Pharmacy, Baylor, Scott & White Health, Texas, | USA

Tammy S. Cohen, BS, PharmD, MS, FASHP, FTSHP, FACHE is the Vice- President of Pharmacy Services at Baylor Scott and White Health in Dallas, Texas. Her responsibilities span pharmacy practice across many settings to include ambulatory care, inpatient and retail practice sites. She oversees the pharmacy services of the 27 hospitals and 31 retail pharmacy locations within BSWH. Tammy leads and serves on many multi-disciplinary committees and has been instrumental in leading financial and operational efficiencies that cross the organization and implementing clinical services. Tammy has been active in several pharmacy organizations. She has been a member of the Texas Society of Health System Pharmacists (TSHP) Board of Directors in various capacities since 2006; most recently she served as the Immediate-Past President. She is also currently a member of the American Society of Health System Pharmacists (ASHP) Pharmacy Executive Leadership Academy. Additional previous TSHP roles include: serving as chair of the Council of Organizational Affairs, Chair of the Section of Pharmacy Management, member of the TSHP Education Council and as the TSHP representative to the Texas State Board Pharmacy (TSBP) Task Force on Internships. Additional organization activities include formal roles with ASHP and the local societies of health system pharmacy along with numerous regulatory related task forces. ASHP experiences include serving on the Council on Legal and Public Affairs, a member of the steering committee for the ASHP Leadership Meeting, the Chair of the Advisory Group on Publications for the Section for Inpatient Practitioners and a member of the Section of Financial Management for the Section of Pharmacy Practice Management. "

Dr. Trisha A. Jordan

PharmD, MS, Chief Pharmacy Officer, Ohio State University Wexner Medical Cente, | USA

"Trisha A. Jordan, PharmD, MS is currently the Chief Pharmacy Officer and Director for the Health-System Pharmacy Administration Residency Program at The Ohio State University Wexner Medical Center and Assistant Dean for Medical Center Affairs at the OSU College of Pharmacy. In her role, Trisha leads pharmacy services across the enterprise, with a focus on providing patient centered pharmacy care through innovation, education and research. After completing undergraduate studies, Trisha received her doctor of pharmacy degree from the University of Michigan and a Master’s degree in health-system pharmacy administration from The Ohio State University. She also completed a pharmacy administration residency at Ohio State and earned a Lean Six Sigma Green Belt certification through the Fisher College of Business at The Ohio State University. Trisha’s professional goals have centered on improving patient care outcomes by creating advanced pharmacy practice models to improve the safety and efficacy in medication use. Her research focuses on pharmacy services and their effect on quality, safety, and cost in addition to the impact of the changing role of the pharmacist in health-systems. She is involved in professional pharmacy organizations and dedicates time to advocacy efforts at the state and national level.

Dr. Majid R. Tanas

PharmD, MHA, MS, FASHP, Vice President of Pharmacy & Chief Pharmacy Officer for Legacy Health. | USA

Dr. Tanas has sought to help others in the profession by mentoring, speaking at conferences, and elevating pharmacy practice at the state and national level. In 2009, Dr. Tanas helped lead the remediation of Oregon Board of Pharmacy findings of non-compliance for Remote IV Dispensing. Through this effort, statutes for Oregon were developed to support Remote IV Dispensing - many of which became a model for others to reference. By this endeavor, oncology-trained Health-System Pharmacists remotely managed Pharmacy Technicians in cleanrooms across 100 miles of freeway. This model allowed Pharmacy Technicians to practice at a higher level as they were able to function independently. As a part of Specialty Pharmacy expansion within Oregon, Dr. Tanas spearheaded the Specialty Pharmacy team to expand critical specialty medications to Oregonians by achieving URAC accreditation, building a specialty program, and developing ambulatory practices to reach more patients. In 2015, The National Institutes of Health Clinical Center had significant FDA 483 findings in their cleanroom. This impact halted much of NIH-sponsored research. After a nationwide search, Dr. Tanas was selected to become the Chief of Pharmacy due to his cleanroom and remediation expertise. During his tenure, he established a team to address significant operational changes to modernize current regulatory practice standards, design the first Health-System cGMP compliant 503A cleanroom, increase the department FTE by nearly double, and expand resources for research. In the midst of a challenging transition, Dr. Tanas made the difficult decision to issue a nationwide recall for medications due to quality concerns. His leadership ultimately led the NIH Clinical Center to initiate a medication safety and quality program and instituted daily organization-wide safety huddles. Currently, Dr. Tanas leads a multi-hospital health system at Legacy Health Pharmacy Services to elevate their cleanroom and regulatory practices. He has directed remodels at five hospitals across the region, upgraded to automated dispensing cabinets for safer medication delivery systems, established a technician-led compliance team for diversion prevention, achieved URAC/ACHC Specialty Pharmacy accreditation, and expanded 340b outpatient clinic services. During the pandemic, his leadership and collaboration with adjoining health systems across the region resulted in the nation's fifth-largest mass vaccination site. Throughout his career, Dr. Tanas has exemplified a commitment to patient safety and compliance by creating unique systems to deliver pharmaceutical care. He continues to give back to the pharmacy community by mentoring student and resident pharmacists to challenge their paradigm around patient care. In addition, he creates opportunities for both technicians and pharmacists to advance their careers in unique care models.

Dr. Ibrahim Al-Khars

MS, MBA, Managing Director, Business Development Manager and Senior Consultant for People & Business Development Center, KSA | Saudi Arabia

Dr. Ibrahim Al-Khars is working as Managing Director, Business Development Manager and Senior Consultant for People & Business Development Center, Dammam, Saudi Arabia. Dr. Al-Khars has a Master in Applied Business Research from Swiss Business School, Switzerland; a Master in Business Administration specialized in International Business from the University of Florida, USA and a special diploma degree in new venture creation from the same university. He received a Bachelor degree in Pharmaceutical Science from King Saud University, Riyadh, Saudi Arabia with honor and Master Degree in Clinical Pharmacy from the same university. His academic history includes a Specialty Residency in Pharmacy Practice Management at Detroit Receiving Hospital and Wayne State University, Detroit, Michigan. His research interests include health care quality improvement, health care reform, the economic evaluation of treatment strategies, health care educational system and technologies, and pharmacy practice management. In addition to his teaching and management activities, Dr. Al-Khars has conducted many presentations, executive seminars and management development programs in different countries including Saudi Arabia, USA, Germany, Malaysia, Lebanon, Oman, Egypt, and United Arab Emirates.

Mr. Jerry Yik

MPubPol, Head of Policy and Advocacy, SHPA, | Australia

Jerry leads SHPA’s diverse policy and advocacy activities, highlighting health and pharmacy policy issues to the relevant stakeholders including parliamentarians, government departments, regulatory bodies, clinical and safety agencies. Harnessing member expertise, SHPA's Policy and Advocacy team demonstrates the continuing expertise, innovation and high standard the hospital pharmacy sector sets, as well as the challenges faced by the sector to provide high quality, safe, equitable and accessible pharmacy services to Australian patients in all healthcare settings.

Dr. Joaquima Serradell

Pharm D; MPH; Ph.D, Temple University Hospital, Philadelphia, PA, | USA

Pharm D; MPH; Ph.D, Temple University Hospital, Philadelphia, PA, USA

Prof. Anna Birna Almarsdóttir

Dr. Anna Birna Almarsdóttir, PhD, MScPharm,University of Copenhagen, Department of Pharmacy, Social and Clinical Pharmacy, Denmark. | Denmark

M.S. Pharmacy University of Iceland 1988 • Community pharmacist 1988-1989 • PhD UNC-Chapel Hill, USA 1994 • DFU 1996-1999 • deCode genetics 1999-2002 • University of Iceland 2002-2013 • University of Southern Denmark (SDU) 2013-2016 • UCPH Department of Pharmacy, Social and Clinical Pharmacy 2016-? • Leader of WHO Collaborating Centre for research and training in the patient perspective on medicines use at UCPH 2018-

Prof. Albert Wertheimer

PhD, MBA,Nova Southeastern University | USA

Dr. Albert Wertheimer has been active in sociobehavioral and administrative pharmacy research and education for more than 30 years. He earned a pharmacy degree at the University of Buffalo, an M.B.A. from the State University of New York at Buffalo and his Ph.D. at Purdue University. In addition, he completed a post-doctoral research fellowship in the department of social medicine at St. Thomas” Hospital Medical School of the University of London. He has directed nearly 100 Ph.D. students and more than that number of master’s students. He is the author or editor of 40 books, numerous book chapters and about 430 journal articles. He has lectured or consulted in about 75 countries, and he holds visiting professor appointments at universities in Mexico, Taiwan, Turkey, Slovenia and China. He performed pioneering work in the area of social and behavioral sciences in pharmacy and in more recent years has conducted research in pharmaco-economics, outcomes research, and health policy analysis. Prior to his appointment at NSU, he has been a professor at Temple University, dean of the Philadelphia College of Pharmacy, a researcher at Merck and Company, a vice president of First Health, Inc., a Pharmacy Benefit Manager and a professor and director of graduate studies at the University of Minnesota. Dr. Wertheimer has received many awards and recognitions including fellowships from the American Association of Pharmaceutical Scientists and the International Pharmacy Federation (FIP). He is Scheele Laureate and an honorary member of several professional societies. He has been a study section member/grant reviewer for the US NIH and for AHRQ. Current research interests include pharmaceutical counterfeiting, off label prescribing and cost:benefit studies.